Cargando…
The In Vivo Selection Method in Breast Cancer Metastasis
Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918415/ https://www.ncbi.nlm.nih.gov/pubmed/33672831 http://dx.doi.org/10.3390/ijms22041886 |
_version_ | 1783657917392617472 |
---|---|
author | Nakayama, Jun Han, Yuxuan Kuroiwa, Yuka Azuma, Kazushi Yamamoto, Yusuke Semba, Kentaro |
author_facet | Nakayama, Jun Han, Yuxuan Kuroiwa, Yuka Azuma, Kazushi Yamamoto, Yusuke Semba, Kentaro |
author_sort | Nakayama, Jun |
collection | PubMed |
description | Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The in vivo selection method and highly metastatic cancer cell lines have contributed to reveal the molecular mechanisms of cancer metastasis. Here, we present an overview of the methodology for the in vivo selection method. Recent comparative analysis of the transplantation methods for metastasis have revealed the divergence of metastasis gene signatures. Even cancer cells that metastasize to the same organ show various metastatic cascades and gene expression patterns by changing the transplantation method for the in vivo selection. These findings suggest that the selection of metastasis models for the study of metastasis gene signatures has the potential to influence research results. The study of novel gene signatures that are identified from novel highly metastatic cell lines and patient-derived xenografts (PDXs) will be helpful for understanding the novel mechanisms of metastasis. |
format | Online Article Text |
id | pubmed-7918415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79184152021-03-02 The In Vivo Selection Method in Breast Cancer Metastasis Nakayama, Jun Han, Yuxuan Kuroiwa, Yuka Azuma, Kazushi Yamamoto, Yusuke Semba, Kentaro Int J Mol Sci Review Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The in vivo selection method and highly metastatic cancer cell lines have contributed to reveal the molecular mechanisms of cancer metastasis. Here, we present an overview of the methodology for the in vivo selection method. Recent comparative analysis of the transplantation methods for metastasis have revealed the divergence of metastasis gene signatures. Even cancer cells that metastasize to the same organ show various metastatic cascades and gene expression patterns by changing the transplantation method for the in vivo selection. These findings suggest that the selection of metastasis models for the study of metastasis gene signatures has the potential to influence research results. The study of novel gene signatures that are identified from novel highly metastatic cell lines and patient-derived xenografts (PDXs) will be helpful for understanding the novel mechanisms of metastasis. MDPI 2021-02-14 /pmc/articles/PMC7918415/ /pubmed/33672831 http://dx.doi.org/10.3390/ijms22041886 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Nakayama, Jun Han, Yuxuan Kuroiwa, Yuka Azuma, Kazushi Yamamoto, Yusuke Semba, Kentaro The In Vivo Selection Method in Breast Cancer Metastasis |
title | The In Vivo Selection Method in Breast Cancer Metastasis |
title_full | The In Vivo Selection Method in Breast Cancer Metastasis |
title_fullStr | The In Vivo Selection Method in Breast Cancer Metastasis |
title_full_unstemmed | The In Vivo Selection Method in Breast Cancer Metastasis |
title_short | The In Vivo Selection Method in Breast Cancer Metastasis |
title_sort | in vivo selection method in breast cancer metastasis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918415/ https://www.ncbi.nlm.nih.gov/pubmed/33672831 http://dx.doi.org/10.3390/ijms22041886 |
work_keys_str_mv | AT nakayamajun theinvivoselectionmethodinbreastcancermetastasis AT hanyuxuan theinvivoselectionmethodinbreastcancermetastasis AT kuroiwayuka theinvivoselectionmethodinbreastcancermetastasis AT azumakazushi theinvivoselectionmethodinbreastcancermetastasis AT yamamotoyusuke theinvivoselectionmethodinbreastcancermetastasis AT sembakentaro theinvivoselectionmethodinbreastcancermetastasis AT nakayamajun invivoselectionmethodinbreastcancermetastasis AT hanyuxuan invivoselectionmethodinbreastcancermetastasis AT kuroiwayuka invivoselectionmethodinbreastcancermetastasis AT azumakazushi invivoselectionmethodinbreastcancermetastasis AT yamamotoyusuke invivoselectionmethodinbreastcancermetastasis AT sembakentaro invivoselectionmethodinbreastcancermetastasis |